NOW AVAILABLE • SHIPPING WITHIN 1-3 BUSINESS DAYS

Your cart

Your cart is empty

Continue shopping

Ozempic Face: What It Is, Why It Happens & What Can Help

Losing weight on a GLP-1 can change more than the number on the scale. Facial volume loss can make skin appear looser, drier, more lined, or less firm. Here's what we know, and what you can actually do about it.

QUICK ANSWER

"Ozempic face" isn't a medical diagnosis or a proven side effect of Ozempic itself. It's a term used to describe visible facial changes that can occur during significant weight loss, especially loss of facial volume. Skincare cannot replace lost volume, but it can help improve the appearance of skin quality, including firmness, hydration, texture and fine lines.

Written by Alec Semersky
CEO & Co-Founder, AforéFirst and corresponding author of the peer-reviewed DermaReverse clinical study
DermaReverse serum, the topical evaluated in a placebo-controlled, split-face clinical study in GLP-1 users

Ozempic face at a glance

What it is
Visible facial changes associated with significant or rapid weight loss
What you may notice
Less facial fullness · loose-looking skin · fine lines · dryness · texture changes
Primary driver
Loss of facial fat and structural volume during weight loss
Can skincare help?
Yes for skin quality. No for replacing lost facial volume.
When changes appear
Timing varies based on the rate and amount of weight loss and individual factors

What are you noticing?

Most facial changes during GLP-1 treatment fall into one of three categories, or a mix. Each one responds to different things.

Volume loss

Hollow cheeks or a sunken appearance

What may helpDiscuss professional options with a qualified medical or aesthetic provider.
Skin quality

Dryness, texture, fine lines or dullness

What may helpConsistent topical skincare designed to support skin quality.
Laxity

Loose-looking skin around the jaw or neck

What may helpSkincare may support the appearance of skin quality, while more pronounced laxity may require professional treatment.

The key distinctionTopical skincare can address skin quality. It cannot replace lost facial fat or facial volume.

What does Ozempic face look like?

The phrase spread as semaglutide and tirzepatide became common in diabetes care and weight management. It's media shorthand, not a medical diagnosis, and facial aging or facial volume loss is not identified as an adverse reaction in the current FDA-approved Ozempic prescribing information.8 It usually describes a cluster of visible changes that may accompany substantial or rapid weight loss:

  • A flatter or more "deflated" look in the cheeksVolume
  • More prominent bone structure and hollowing under the eyes
    Volume
  • Skin that appears looser along the jawline and neckLaxity
  • Fine lines and folds that look more noticeableSkin quality
  • Drier, duller or rougher-looking skinSkin quality
  • An overall tired or gaunt appearanceMixed

Some people prefer "GLP face" or "GLP-1 face," since the same facial changes are reported across GLP-1 medications such as Ozempic®, Wegovy®, Zepbound® and Mounjaro®, and with rapid weight loss by any method.

Skin quality vs. facial volume vs. laxity

When someone says their face "looks different" or their skin is "sagging," they're usually noticing one of these three things. Knowing which one you're seeing is the key to knowing what will actually help.

Skin quality is how skin looks and feels overall: hydration, firmness, texture, smoothness, radiance, tone, pores and fine lines. This is where a consistent topical routine is most relevant.

Volume is fullness beneath the skin. Topical skincare cannot replace lost facial volume. Volume concerns are a conversation for a qualified aesthetic provider.

Laxity is looseness or reduced support in the skin or underlying tissue, and it's what most people mean by loose skin after weight loss. Mild laxity overlaps with skin quality; deeper laxity is best evaluated by a provider.

Approach Skin qualityhydration, texture, lines, firmness Volumefullness beneath the skin Laxitylooseness, reduced support
Consistent skincarePeptides, hyaluronic acid, retinoids, antioxidants, daily SPF
Main option

Where a topical routine is most relevant.
Can't replace

No topical restores lost fullness.
Mild only

Mild laxity overlaps with skin quality.

Everyday habitsProtein, resistance training, hydration, sun protection
Supports

Hydration and daily SPF support skin quality over time.
Indirect

Discuss a healthy rate of weight loss with your clinician.
Indirect

Protein and resistance training help support muscle.

Professional treatmentBy a licensed provider: fillers, energy-based devices, microneedling, surgery
Some options

Microneedling and energy-based devices.
Main option

Injectable fillers to restore volume.
Main option

Skin-tightening devices; surgery for significant loose skin.
●●● main option●●○ helps●○○ limited or indirect○○○ won't help

Plain-English definitions of each term are in our GLP-1 skin glossary.

Where skincare fits

Topical skincare can't restore lost facial volume. But it can address the visible quality of the skin itself.

DermaReverse was developed for visible skin-quality changes people may experience during a GLP-1 journey and evaluated in a peer-reviewed, placebo-controlled clinical study.

See what was studied →

What actually helps Ozempic face?

Options range from everyday habits and consistent skincare to professional procedures. The right approach depends on whether your main concern is volume, skin quality, or both.

For your overall health and skin

Support your body from the inside

  • Pace: discuss a healthy rate of weight loss with your clinician. Never change your medication, dose or schedule for a cosmetic concern without speaking with your prescriber.
  • Protein: supports the maintenance of muscle and other tissues. A clinician or registered dietitian can help determine what's right for you.
  • Resistance training, when medically appropriate, helps support muscle during weight loss.
  • Hydration: some people eat or drink less during treatment, and GI side effects can contribute to dehydration.8
  • Daily broad-spectrum SPF is one of the most consistently recommended steps for skin quality over time.
For skin quality

A consistent skincare routine

Skincare during GLP-1 treatment can't change your weight or replace lost volume, but these ingredients can help skin look firmer, smoother and more hydrated:

  • Peptides support the look of firmness.
  • Hyaluronic acid supports a hydrated, plumper-looking surface.
  • Retinol and cosmetic vitamin A derivatives support smoother texture and fewer visible fine lines.
  • Antioxidants such as vitamin C support a brighter, more even-looking complexion.
GLP-1 skincare routine, morning and night →How to use DermaReverse →
For volume and pronounced laxity

Professional options

For more pronounced changes, some people consult a board-certified dermatologist or plastic surgeon. These are medical procedures by licensed providers, not skincare, and may include:

  • Injectable fillers to restore volume
  • Energy-based skin-tightening procedures
  • Microneedling
  • Surgical options for significant loose skin
Skincare vs. in-office treatments →

Why does Ozempic face happen?

Several factors may contribute, and they can overlap. Rapid facial fat loss is the best-established explanation. These changes are generally associated with significant or rapid weight loss rather than established as a direct effect of the medication.

Best established

Rapid fat loss

Facial fat gives the skin underlying volume. The face contains fat compartments that contribute to a smooth, full appearance. When they shrink quickly, the skin over them can look deflated, looser or more lined.

Collagen & elastin

Skin may take time to adjust

Collagen and elastin help give skin its firm, resilient appearance, and their levels decline with age. After substantial or rapid weight loss, skin may not visibly adjust to smaller facial contours at the same pace, so lines or laxity look more noticeable.

Lean mass

Changes in muscle and underlying support

Weight loss can include both fat and lean mass. Because muscle contributes to the underlying support of the face and body, clinicians often discuss adequate protein and resistance training as part of a medically supervised plan.

Nutrition

Nutrients and hydration

Healthy skin renewal depends on adequate nutrients including vitamin A and other micronutrients,7 and appetite, food intake and hydration can all change during GLP-1 treatment. Individual needs are best discussed with your prescribing clinician or a registered dietitian.

Emerging research · not yet proven

The quality of the skin itself

Researchers are examining whether GLP-1-based medications may influence skin biology in addition to producing weight loss. A 2024 review in Aesthetic Surgery Journal described GLP-1-related facial changes as potentially multifactorial, involving loss of dermal and subcutaneous fat, altered activity of adipose-derived stem cells, and downstream effects on the skin's supportive environment.1 GLP-1 is a signaling molecule with activity throughout the body,2 and laboratory and clinical research has shown that GLP-1 receptor agonists can act on keratinocytes and influence inflammatory signaling and wound-healing pathways.3,4 GLP-1 therapy has also been studied in connection with inflammatory skin conditions such as psoriasis,5 and broader safety literature continues to examine effects associated with this medication class.6

This provides a basis for continued research, but it does not establish that GLP-1 medications directly cause changes in human facial skin independent of weight loss.

When does Ozempic face start?

There's no fixed timeline, and experiences vary. In general, visible facial changes track the pace and amount of weight loss: the faster or greater the loss, the more noticeable the change may be.

Starting treatment

Little visible change

Facial changes usually aren't visible yet. Some people start a skincare routine here. Preparing your skin →

The first several months

Changes may become noticeable

Some people notice differences as fat reduction becomes visible in the face. Others notice little or no change.

At a stable weight

Appearance can keep evolving

Some changes may soften once weight stabilizes; others may persist. A realistic timeline →

Concerned about the pace of your weight loss? Speak with your prescribing clinician. Do not change your medication, dose or schedule to address a cosmetic concern without medical guidance.

Does Ozempic face go away?

There isn't enough long-term clinical evidence to predict how often these changes improve after weight stabilizes. Some visible changes may soften, while others may persist. What happens over time depends on:

  • Age and skin elasticitySkin with greater natural elasticity may adapt more readily to changing contours.
  • How fast and how much weight was lostLarger or faster changes can make volume loss and laxity more visible.
  • Time at a stable weightAppearance may continue to evolve after weight loss slows or stabilizes.
  • The type of changeLost volume, surface dehydration, visible lines and laxity are different concerns that respond to different approaches.

We go deeper in Does Ozempic face go away? and Skin after stopping a GLP-1.

Who is most likely to notice GLP-1 facial changes?

You may be more likely to see noticeable facial changes if you:

  • Are losing weight quicklyor have lost a substantial amount
  • Are olderskin elasticity naturally decreases with age
  • Have had significant sun exposureover time
  • Started with more facial fullnessthat is now decreasing

None of these factors guarantees a change. Individual experiences vary, and the changes described by the term are cosmetic rather than a medical diagnosis.

Ozempic face vs. normal aging

The visible changes overlap, which is why they can be hard to tell apart.

Normal aging

Gradual, over years

Age-related loss of facial volume and skin quality typically develops slowly.

During a GLP-1 journey

Can appear more quickly

Changes often track the pace of weight loss.

In practice the concerns look similar (less fullness, more noticeable lines, skin that appears less firm), and many of the approaches that support appearance overlap.

What clinical research shows

Studied in GLP-1 users. Not simply marketed to them.

Most skincare marketed to GLP-1 users is general-purpose skincare with a new label. DermaReverse was evaluated in a published clinical study in people using GLP-1 therapy.

Peer reviewedPublished in Aesthetic Surgery Journal Open Forum
Placebo controlledEach participant served as her own control in a split-face study
13 skin-quality measuresEvaluated across the six-week study
GLP-1 usersThe finished topical formula was evaluated in women using GLP-1 receptor agonist or SGLT-2 therapy
Study participant's lower face at Day 1, baseline, before DermaReverse use
The same participant at Day 42, after six weeks of twice-daily DermaReverse use
Day 1Day 42

Photographs are of a single study participant and have not been retouched. Individual results vary.

  • 6 weeks
  • Twice daily
  • Blinded
  • Placebo-controlled
  • Split-face
  • Peer-reviewed
Visible improvement by Day 21, with additional improvement by Day 42 The DermaReverse-treated side showed statistically significant improvement compared with the placebo side across the measured parameters. No adverse events were reported. Individual results vary.
  • Design
    Single-center, blinded, placebo-controlled, split-face. DermaReverse on one side of the face, placebo on the other, twice daily for six weeks.
  • Participants
    A pilot group of seven women, ages 34 to 64 (median 55), using GLP-1 or SGLT-2 therapy, with visible skin-quality concerns and a stable weight during the study.
  • Measured
    13 visible skin-quality parameters on the Global Ranking Scale, including elasticity, surface roughness, dehydration, static and dynamic wrinkles, volume loss, sagging, pores, pigmentation and vasculature, at baseline, Day 21 and Day 42.
  • Published
    Peer-reviewed and open access in Aesthetic Surgery Journal Open Forum, 2025, with Alec Semersky as first and corresponding author.9

This was a pilot study. A split-face design is unusually informative per participant because it removes person-to-person variation, but it is one study. It evaluated DermaReverse's cosmetic effects in GLP-1 users; it was not designed to determine what caused participants' underlying skin concerns. Aforé sponsored the study.

Read the Published Study Explore DermaReverse

Plain-English study summary · Ingredient list

Why this is uncommon in skincare

Claims for skincare marketed to GLP-1 users are typically supported by consumer perception surveys, studies of a single ingredient rather than the finished formula, or results that are summarized but never published in full. DermaReverse's study:

  • Was IRB-approved
  • Tested the finished formula, not a single ingredient
  • Was published in a medical journal after peer review
  • Is open access, so anyone can read and check the full results
DermaReverse and where skincare fits

Your weight-loss journey is changing. Your skincare can too.

One serum. 13 measured skin-quality parameters. Six weeks of clinical evaluation.

DermaReverse is a twice-daily cosmetic serum designed to support the appearance of firmer, smoother, more hydrated, resilient-looking skin during and after significant weight change. Aforé developed it specifically for visible skin-quality changes during a GLP-1 journey, rather than adapting a general anti-aging product.

Explore DermaReverse →
How to useIngredientsClinical study

Cosmetic skincare cannot restore facial volume or replace medical or aesthetic treatment. Individual results vary. DermaReverse is a topical skincare product, not a drug.

Frequently asked questions

Is Ozempic face caused by the medication?

That has not been established. Substantial or rapid weight loss can reduce facial fat and make skin look looser or more lined, whether the weight loss occurs with GLP-1 therapy or another method. Emerging research is exploring whether GLP-1-based medications may also influence skin biology, but direct effects on human facial skin independent of weight loss have not been proven.

When does Ozempic face start?

There is no fixed timeline. Visible facial changes generally track the pace and amount of weight loss. Some people notice differences within the first several months as fat reduction becomes visible in the face; others notice little or no change.

Will Ozempic face go away on its own?

There is limited long-term evidence, and experiences vary. Some visible changes may soften after weight stabilizes, while lost facial volume or more pronounced laxity may persist. Skincare can support the appearance of firmness, smoothness and hydration, but it cannot replace lost facial volume.

Is Ozempic face permanent?

Not necessarily, but there is not enough long-term evidence to predict an individual outcome. Age, skin elasticity, the amount and pace of weight loss, and whether the primary concern is volume or skin quality all influence how appearance evolves.

Can skincare fix Ozempic face?

Skincare cannot change your weight or replace lost facial volume. It can support visible skin quality. Ingredients such as peptides, hyaluronic acid, retinol and antioxidants can help skin look firmer, smoother and more hydrated as part of a consistent routine. DermaReverse was the first topical skin solution designed for GLP-1 users to be the subject of a peer-reviewed, medical-journal-published study.

How can I improve or reduce Ozempic face while losing weight?

No approach can guarantee prevention. Common supportive steps include discussing an appropriate rate of weight loss with your clinician, eating adequate protein, resistance training when medically appropriate, staying hydrated, daily sun protection and a consistent skincare routine. For volume loss or pronounced laxity, a qualified aesthetic provider can discuss professional options. Do not change your medication or dose without speaking with your prescriber.

Does the same thing happen with Wegovy, Zepbound or Mounjaro?

The visible changes people describe as "Ozempic face" are associated with substantial or rapid weight loss rather than one brand. Similar changes are reported across GLP-1 and GIP/GLP-1 medications and across rapid weight loss by any method.

What's the difference between facial volume loss and skin quality?

Volume is the fullness beneath the skin, mostly from facial fat. Skin quality is how the skin itself looks and feels: hydration, texture, firmness, fine lines and radiance. Topical skincare can address skin quality; it cannot replace lost facial volume, which is a conversation for a qualified aesthetic provider.

Go deeper: GLP-1 skin guides

Each guide answers one question in depth.

Showing 14 of 14 guides

About the author

Alec Semersky is CEO, co-founder and formulator of Aforé. He is first and corresponding author of the 2025 placebo-controlled, split-face clinical study of DermaReverse in GLP-1 users, and co-author of six further medical journal publications in skincare and aesthetic medicine dating to 2016.

Read more about Alec · See all seven publications

References (9)
  1. Ridha Z, Fabi SG, Zubair R, Dayan SH. Decoding the Implications of Glucagon-like Peptide-1 Receptor Agonists on Accelerated Facial and Skin Aging. Aesthetic Surgery Journal. 2024;44(11):NP809–NP818. doi:10.1093/asj/sjae132
  2. Holst JJ. The Physiology of Glucagon-like Peptide 1. Physiological Reviews. 2007;87(4):1409–1439. doi:10.1152/physrev.00034.2006
  3. Yang J, Wang Z, Zhang X. GLP-1 receptor agonist impairs keratinocytes inflammatory signals by activating AMPK. Experimental and Molecular Pathology. 2019;107:124–128. doi:10.1016/j.yexmp.2019.01.014
  4. Nagae K, Uchi H, Morino-Koga S, et al. Glucagon-like peptide-1 analogue liraglutide facilitates wound healing by activating PI3K/Akt pathway in keratinocytes. Diabetes Research and Clinical Practice. 2018;146:155–161. doi:10.1016/j.diabres.2018.10.013
  5. Xu X, Lin L, Chen P, et al. Treatment with liraglutide, a glucagon-like peptide-1 analogue, improves effectively the skin lesions of psoriasis patients with type 2 diabetes: a prospective cohort study. Diabetes Research and Clinical Practice. 2019;150:167–173. doi:10.1016/j.diabres.2019.03.002
  6. Filippatos TD, Panagiotopoulou TV, Elisaf MS. Adverse Effects of GLP-1 Receptor Agonists. Review of Diabetic Studies. 2014;11(3-4):202–230. doi:10.1900/RDS.2014.11.202
  7. VanBuren CA, Everts HB. Vitamin A in Skin and Hair: An Update. Nutrients. 2022;14(14):2952. doi:10.3390/nu14142952
  8. U.S. Food and Drug Administration. Ozempic (semaglutide) Prescribing Information. Revised May 2026. FDA prescribing information
  9. Semersky A, Pryor S, Barwood-Parent C, Lee M, Copeland K, Few J. A Single-Center, Blinded, Placebo-Controlled Study Evaluating Cosmetic Efficacy and Safety of a Novel Topical GLPSGLT in Glucagon-Like Peptide-1 Analog-Treated Patients. Aesthetic Surgery Journal Open Forum. 2025;7:ojaf030. doi:10.1093/asjof/ojaf030

Disclaimer: Aforé and DermaReverse are independent and are not affiliated with, endorsed by, sponsored by, or connected to the makers of any GLP-1 medication. Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S, and Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. Aforé claims no ownership of these marks; they are used here only to identify the medications discussed. All other trademarks are the property of their respective owners. "Ozempic face" is an informal, non-medical term and is not a diagnosis. This page discusses cosmetic, appearance-level changes in facial volume and skin quality; it does not establish that any medication causes a disease, medical condition, or specific cosmetic change. References to scientific research are provided for general educational context and include an emerging and evolving area of study. Aforé is a cosmetic skincare company; this content is not medical advice and is not a substitute for consultation with a qualified healthcare provider. Do not change any medication, dose, or treatment plan without speaking with your prescribing clinician. None of Aforé's products are intended to diagnose, treat, cure, or prevent any disease. Individual results vary.

Put it into practice

A simple morning routine for skin that's changing on a GLP-1. Cleanse, then these three, in this order. In the evening, use the first two and skip the SPF.

  1. DermaReverse Step 1 DermaReverse $145 or $99/month with a subscription First, on clean, dry skin. 3 to 4 drops over face, neck and décolletage.
  2. Moisture Complete Step 2 Moisture Complete $95 $60 Next, smooth over face and neck to lock everything in.
  3. Tinted Mineral Sunscreen SPF 30 Step 3 Tinted Mineral Sunscreen SPF 30 $85 $60 Last, every morning. Reapply every 2 hours in the sun.

All three: $265

DermaReverse is added as a one-time purchase. Prefer a subscription? Start on the DermaReverse page.

Build your own routine instead